The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors
- 319 Downloads
Endoscopic resection has been used to treat small rectal neuroendocrine tumors (NETs). However, the indication for additional surgery after endoscopic resection is unclear. The aim of this study was to identify risk factors for rectal NET metastasis and to determine the indication for additional surgery.
Fifty-five patients with a total of 57 rectal NETs, treated between October 2003 and January 2013, were retrospectively divided into metastatic (11 lesions) and non-metastatic (46 lesions) groups. Tumor size, central depression, invasion depth, lymphatic and venous permeation, mitotic activity, nuclear abnormality, Ki-67 labeling index, and World Health Organization grading classification (G1 or G2) were compared between the groups. Patients underwent endoscopic submucosal resection with a ligation device, transanal full-thickness surgical resection, or radical surgery.
By univariate analysis, the odds ratios (OR) for a Ki-67 labeling index >3.0 %, positive lymphatic or venous permeation, World Health Organization grading classification G2, tumor size >10 mm, submucosal invasion >4000 μm, and central depression were 120 (P < 0.001), 67.6 (P < 0.001), 58.7 (P < 0.001), 9.8 (P = 0.0037), 6.8 (P = 0.012), and 5.7 (P = 0.018), respectively. Multivariate logistic regression analyses showed that vascular permeation (OR 111; P = 0.006) and a Ki-67 labeling index >3.0 % (OR 88; P = 0.012) were independent risk factors for metastasis.
The Ki-67 labeling index and lymphatic/venous permeation were reliable predictors of rectal NET metastases.
KeywordsRectal NET Metastasis Predictor Ki-67 labeling index Lymphatic permeation Venous permeation
Compliance with ethical standards
Shinya Sugimoto, Kinichi Hotta, Tadakazu Shimoda, Kenichiro Imai, Yuichiro Yamaguchi, Takashi Nakajima, Takuma Oishi, Keita Mori, Kohei Takizawa, Naomi Kakushima, Masaki Tanaka, Noboru Kawata, Hiroyuki Matsubayashi, and Hiroyuki Ono have disclosed that they have no significant relationships or financial interests with any commercial companies pertaining to this article.
- 3.Soga J (1994) Carcinoid tumors: a statistical analysis of a Japanese series of 3126 reported and 1180 autopsy cases. Acta Med Biol 42:87–102Google Scholar
- 4.Bosman FT, Carneiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system. World Health Organization, GenevaGoogle Scholar
- 18.Caplin M, Sundin A, Nillson O, Baum RP, Klose KJ, Kelestimur F, Plöckinger U, Papotti M, Salazar R, Pascher A, Barcelona Consensus Conference Participants (2012) ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 95:88–97CrossRefPubMedGoogle Scholar